Murakami Y, Minami M, Daimon Y, et al. Hepatitis B virus DNA in liver, serum, and peripheral blood mononuclear cells after the clearance of serum hepatitis B virus surface antigen[J]. J Med Virol, 2004, 72(2): 203-214.
[2]
Laure FD. Zagury AG. Saimot RC, et al. Hepatitis B virus DNA sequences in lymphoid cells from patients with AIDS and AIDS-related complex[J]. Science, 1985, 229(4713): 561-563.
[3]
Wang Y, Lau HS, Sham JS, et al. Characterization of HBV integrants in 14 hepatocellular carcinomas: association of truncated X gene and hepatocellualr carcinogenesis[J]. Oncogene, 2004, 23(1): 142-148.
[4]
Buendia MA. Hepatitis B viruses and hepatocellular carcinoma[J]. Adv Cancer Res, 1992, 59: 167-226.
[5]
Robinson WS. Molecular events in the pathogenesis of hepadnavirus- associated hepatocellular carcinoma[J]. Annu Rev Med, 1994, 45: 297-323.
[6]
Block TM, Mehta AS, Fimmel CJ, et al. Molecular viral oncology of hepatocellular carcinoma[J]. Oncogene, 2003, 22(33): 5093-5107.
[7]
Jayshree RS, Sridhar H, Devi GM. Surface, core, and X genes of hepatitis B virus in hepatocellular carcinoma: an in situ hybridization study[J]. Cancer, 2003, 99(1): 63-67.
Wang HP, Rogler CE. Topoisomerase I-mediated integration of hepadnavirus DNA in vitro[J]. J Virol, 1991, 65(5): 2381-2392.
[10]
Yuwen H, Hsia CC, Nakashima Y, et al. Binding of wild-type p53 by topoisomerase II and overexpression of topoisomerase II in human hepatocellular carcinoma[J]. Biochem Biophys Res Commun, 1997, 234(1): 194-197.
[11]
Menne S, Tennant BC. Unraveling hepatitis B virus infection of mice and men (and woodchucks and ducks)[J]. Nat Med, 1999, 5(10): 1125- 1126.
[12]
Hwong CL, Chen CY, Shang HF, et al. Increased synthesis and degradation of DNA topoisomerase I during the initial phase of human T lymphocyte proliferation[J]. J Biol Chem, 1993, 268(25): 18982-18986.
Minami M, Poussin K, Brechot C, et al. A novel PCR technique using Alu-specific primers to identify unknown flanking sequences from the human genome[J]. Genomics, 1995, 29(2): 403-408.
Block TM, Mehta AS, Fimmel CJ, et al. Molecular viral oncology of hepatocellular carcinoma[J]. Oncogene, 2003, 22(33): 5093-5107.
[17]
Murakami S. Hepatitis B virus X protein: a multifunctional viral regulator[J]. J Gastroenterol, 2001, 36(10): 651-660.
[18]
Yasui H, Hino O, Ohtake K, et al. Clonal growth of hepatitis B virus-integrated hepatocytes in cirrhotic liver nodules[J]. Cancer Res, 1992, 52(24): 6810-6814.
[19]
Zimonjic DB, Keck CL, Thorgeirsson SS, et al. Novel recurrent genetic imbalances in human hepatocellular carcinoma cell lines identified by comparative genomic hybridization[J]. Hepatol, 1999, 29(4): 1208-1214.
[20]
Murakami Y, Minami M, Daimon Y, et al. Hepatitis B virus DNA in liver, serum, and peripheral blood mononuclear cells after the clearance of serum hepatitis B virus surface antigen[J]. J Med Virol, 2004, 72(2): 203- 214.
[21]
Laskus T, Radkowski M, Wang LF, et al. Detection and sequence analysis of hepatitis B virus integration in peripheral blood mononuclear cells[J]. J Virol, 1999, 73(2): 1235-1238.
